Interpace Diagnostics Group, Inc.·4

Mar 15, 4:56 PM ET

Early James 4

4 · Interpace Diagnostics Group, Inc. · Filed Mar 15, 2019

Insider Transaction Report

Form 4
Period: 2019-03-13
Early James
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2019-03-13+26,34043,340 total
  • Award

    Stock Option (right to buy)

    2019-03-13+105,360105,360 total
    Exercise: $0.98Exp: 2029-03-13Common Stock (105,360 underlying)
Footnotes (3)
  • [F1]The restricted stock units vest annually, in equal installments, over a three-year period, commencing on March 13, 2020.
  • [F2]Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
  • [F3]The stock options vest and become exercisable over a three-year period, in equal installments, commencing on March 13, 2020, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT